2022 annual financial data
Stoke Therapeutics 2022 Operating margin
Stoke Therapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was -841.24%.
Operating income was -104,356,000 USD and net income was -93,110,000 USD.
Operating cash flow was -31,866,000 USD.
Get free Stoke Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 12,405,000 USD
- Operating income
- -104,356,000 USD
- Net income
- -93,110,000 USD
- Operating cash flow
- -31,866,000 USD